Cargando…

Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches

The papain-like protease (PL(pro)) is vital for the replication of coronaviruses (CoVs), as well as for escaping innate-immune responses of the host. Hence, it has emerged as an attractive antiviral drug-target. In this study, computational approaches were employed, mainly the structure-based virtua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alamri, Mubarak A., Tahir ul Qamar, Muhammad, Mirza, Muhammad Usman, Alqahtani, Safar M., Froeyen, Matheus, Chen, Ling-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Xi'an Jiaotong University 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453225/ https://www.ncbi.nlm.nih.gov/pubmed/32874702 http://dx.doi.org/10.1016/j.jpha.2020.08.012

Ejemplares similares

Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease
por: Mirza, Muhammad Usman, et al.
Publicado: (2020)

Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants
por: Tahir ul Qamar, Muhammad, et al.
Publicado: (2020)

Discovery of anti-MERS-CoV small covalent inhibitors through pharmacophore modeling, covalent docking and molecular dynamics simulation
por: Alamri, Mubarak A., et al.
Publicado: (2021)

Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase
por: Mirza, Muhammad Usman, et al.
Publicado: (2020)

Discovery of Rift Valley fever virus natural pan-inhibitors by targeting its multiple key proteins through computational approaches
por: Fatima, Israr, et al.
Publicado: (2022)

Targeting papain-like protease for broad-spectrum coronavirus inhibition
por: Yuan, Shuofeng, et al.
Publicado: (2022)

Structural and functional characterization of MERS coronavirus papain-like protease
por: Lin, Min-Han, et al.
Publicado: (2014)

Epitope‐based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study
por: Tahir ul Qamar, Muhammad, et al.
Publicado: (2019)

Structural Elucidation of Rift Valley Fever Virus L Protein towards the Discovery of Its Potential Inhibitors
por: Alamri, Mubarak A., et al.
Publicado: (2022)

Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking
por: Ibrahim, Tamer M., et al.
Publicado: (2020)

Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19
por: Hersi, Fatema, et al.
Publicado: (2023)

Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease
por: Lindner, Holger A., et al.
Publicado: (2007)

The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy
por: Mohamud, Yasir, et al.
Publicado: (2021)

Network pharmacology based virtual screening of Flavonoids from Dodonea angustifolia and the molecular mechanism against inflammation
por: Alamri, Mubarak A., et al.
Publicado: (2023)

Coronavirus Papain-like Peptidases
por: Ratia, Kiira, et al.
Publicado: (2013)

Analyzing the effect of mutations in SARS-CoV2 papain-like protease from Saudi isolates on protein structure and drug-protein binding: Molecular modelling and dynamics studies
por: Alabbas, Alhumaidi B., et al.
Publicado: (2022)

The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
por: Báez-Santos, Yahira M., et al.
Publicado: (2015)

Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
por: Chou, Chi-Yuan, et al.
Publicado: (2008)

Chemical screen uncovers novel structural classes of inhibitors of the papain-like protease of coronaviruses
por: Jeong, Kwiwan, et al.
Publicado: (2022)

Molecular and Structural Analysis of Specific Mutations from Saudi Isolates of SARS-CoV-2 RNA-Dependent RNA Polymerase and their Implications on Protein Structure and Drug–Protein Binding
por: Alamri, Mubarak A., et al.
Publicado: (2022)

Role of Papain-Like Cysteine Proteases in Plant Development
por: Liu, Huijuan, et al.
Publicado: (2018)

Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
por: Lin, Min-Han, et al.
Publicado: (2018)

Differential domain structure stability of the severe acute respiratory syndrome coronavirus papain-like protease
por: Chou, Ya-Wen, et al.
Publicado: (2012)

Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability
por: Qiu, Yue, et al.
Publicado: (2022)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

In Vitro Antidiabetic, Anti-Obesity and Antioxidant Analysis of Ocimum basilicum Aerial Biomass and in Silico Molecular Docking Simulations with Alpha-Amylase and Lipase Enzymes
por: Noor, Zoy I, et al.
Publicado: (2019)

Deubiquitinating Activity of the SARS-CoV Papain-Like Protease
por: Barretto, Naina, et al.
Publicado: (2006)

Structure determinants defining the specificity of papain-like cysteine proteases
por: Petushkova, Anastasiia I., et al.
Publicado: (2022)

Synergistic Inhibitor Binding to the Papain‐Like Protease of Human SARS Coronavirus: Mechanistic and Inhibitor Design Implications
por: Lee, Hyun, et al.
Publicado: (2013)

Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease
por: Békés, Miklós, et al.
Publicado: (2016)

p53 Degradation by a Coronavirus Papain-like Protease Suppresses Type I Interferon Signaling
por: Yuan, Lin, et al.
Publicado: (2015)

The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species
por: Niemeyer, Daniela, et al.
Publicado: (2018)

Protocol for in vitro fluorescence assay of papain-like protease and cell-based immunofluorescence assay of coronavirus infection
por: Chang, JuOae, et al.
Publicado: (2023)

Nidovirus papain-like proteases: Multifunctional enzymes with protease, deubiquitinating and deISGylating activities
por: Mielech, Anna M., et al.
Publicado: (2014)

Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease: Parthenolide covalently inhibits papain-like protease
por: Zou, Zhihui, et al.
Publicado: (2022)

In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors
por: Mirza, Muhammad Usman, et al.
Publicado: (2019)

In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2
por: Bhattacharya, Kunal, et al.
Publicado: (2022)

Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features
por: Lei, Jian, et al.
Publicado: (2014)

Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus
por: Cheng, Kai-Wen, et al.
Publicado: (2015)

Investigating Fungi-Derived Bioactive Molecules as Inhibitor of the SARS Coronavirus Papain Like Protease: Computational Based Study
por: Belachew, Aweke Mulu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_au9od0nvmglvqgc1qph2splbbu